ArticleCancers2022
FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
Yi-Tsung Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleCancers2022
Yi-Tsung Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.